Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Aart C, Strang"'
Autor:
Michael J, Blans, Aart C, Strang
Publikováno v:
Chest. 161(6)
Autor:
Olaf R.F. Mook, Ard Jonker, Aart C. Strang, Andor Veltien, Giulio Gambarota, Wilma M. Frederiks, Arend Heerschap, Cornelis J.F. Van Noorden
Publikováno v:
BioTechniques, Vol 44, Iss 4, Pp 529-535 (2008)
Monitoring tumor development is essential for the understanding of mechanisms involved in tumor progression and to determine efficacy of therapy. One of the evolving approaches is longitudinal noninvasive magnetic resonance imaging (MRI) of tumors in
Externí odkaz:
https://doaj.org/article/69b2e88123464522a5b64505c30656c1
Autor:
Michael J. Blans, Aart C. Strang
Publikováno v:
Chest. 161:e400-e401
Autor:
Diederik F van Wijk, Aart C Strang, Raphael Duivenvoorden, Dirk-Jan F Enklaar, Aeilko H Zwinderman, Rob J van der Geest, John J P Kastelein, Eric de Groot, Erik S G Stroes, Aart J Nederveen
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0130878 (2015)
PurposeDifferent in-plane resolutions have been used for carotid 3T MRI. We compared the reproducibility, as well as the within- and between reader variability of high and routinely used spatial resolution in scans of patients with atherosclerotic ca
Externí odkaz:
https://doaj.org/article/de40271764c74a4c9f74659e08429c81
Autor:
Aart C Strang, Menno L W Knetsch, Leo H Koole, Robbert J de Winter, Allard C van der Wal, Carlie J M de Vries, Paul P Tak, Radjesh J Bisoendial, Erik S G Stroes, Joris I Rotmans
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0122836 (2015)
Since high-density lipoprotein (HDL) has pro-endothelial and anti-thrombotic effects, a HDL recruiting stent may prevent restenosis. In the present study we address the functional characteristics of an apolipoprotein A-I (ApoA-I) antibody coating in
Externí odkaz:
https://doaj.org/article/354191a2f30a4e808cd1418e43f51f8b
Autor:
Matthijs S Ruiter, Claudia M van Tiel, Albert Doornbos, Goran Marinković, Aart C Strang, Nico J M Attevelt, Vivian de Waard, Robbert J de Winter, Rob Steendam, Carlie J M de Vries
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0138459 (2015)
The introduction of drug-eluting stents (DES) has dramatically reduced restenosis rates compared with bare metal stents, but in-stent thrombosis remains a safety concern, necessitating prolonged dual anti-platelet therapy. The drug 6-Mercaptopurine (
Externí odkaz:
https://doaj.org/article/03a0521f57254233ae1b676b203c4f4f
Autor:
Michela Botta, Anissa M Tsonas, Janesh Pillay, Leonoor S Boers, Anna Geke Algera, Lieuwe D J Bos, Dave A Dongelmans, Marcus W Hollmann, Janneke Horn, Alexander P J Vlaar, Marcus J Schultz, Ary Serpa Neto, Frederique Paulus, Jesse P. van Akkeren, Cheetel K. Algoe, Rombout B. van Amstel, Onno L. Baur, Pablo van de Berg, Alida E. van den Berg, Dennis C.J.J. Bergmans, Dido I. van den Bersselaar, Freke A. Bertens, Alexander J.G.H. Bindels, Milou M. de Boer, Sylvia den Boer, Leonoor S. Boers, Margriet Bogerd, Lieuwe D.J. Bos, Jennifer S. Breel, Hendrik de Bruin, Sanne de Bruin, Caro L. Bruna, Laura A. Buiteman-Kruizinga, Olaf L. Cremer, Rogier M. Determann, Willem Dieperink, Dave A. Dongelmans, Hildegard S. Franke, Michal S. Galek-Aldridge, Mart J. de Graaff, Laura A. Hagens, Jasper J. Haringman, Sebastiaan T. van der Heide, Pim L.J. van der Heiden, Nanon F.L. Heijnen, Stephan J.P. Hiel, Lotte L. Hoeijmakers, Liselotte Hol, Markus W. Hollmann, Marga E. Hoogendoorn, Robrecht van der Horst, Evy L.K. Ie, Dimitri P. Ivanov, Nicole Juffermans, Eline Kho, Eline S. de Klerk, Ankie W.M.M. Koopman-van Gemert, Matty Koopmans, Songul Kucukcelebi, Michael A. Kuiper, Dylan W. de Lange, Niels van Mourik, Sunny G.L.H. Nijbroek, Marisa Onrust, Evelien A.N. Oostdijk, Charlotte J. Pennartz, Luigi Pisani, Ilse M. Purmer, Thijs C.D. Rettig, Jan-Paul Roozeman, Michiel T.U. Schuijt, Marcus J. Schultz, Mengalvio E. Sleeswijk, Marry R. Smit, Peter E. Spronk, Willemke Stilma, Aart C. Strang, Anissa M. Tsonas, Pieter R. Tuinman, Christel M.A. Valk, Felicia L. Veen-Schra, Lars I. Veldhuis, Patricia van Velzen, Ward H. van der Ven, Alexander P.J. Vlaar, Peter van Vliet, Peter H.J. van der Voort, Louis van Welie, Henrico J.F.T. Wesselink, Hermien H. van der Wier-Lubbers, Bas van Wijk, Tineke Winters, Wing Yi Wong, Arthur R.H. van Zanten
Publikováno v:
lancet. Respiratory medicine, 9(2), 139-148. Elsevier Limited
The Lancet. Respiratory Medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier
Botta, M, Tsonas, A M, Pillay, J, Boers, L S, Algera, A G, Bos, L D J, Dongelmans, D A, Hollmann, M W, Horn, J, Vlaar, A P J, Schultz, M J, Neto, A S, Paulus, F, van Akkeren, J P, Algoe, C K, van Amstel, R B, Baur, O L, van de Berg, P, van den Berg, A E, Bergmans, D C J J, van den Bersselaar, D I, Bertens, F A, Bindels, A J G H, de Boer, M M, den Boer, S, Boers, L S, Bogerd, M, Bos, L D J, Breel, J S, de Bruin, H, de Bruin, S, Bruna, C L, Buiteman-Kruizinga, L A, Cremer, O L, Determann, R M, Dieperink, W, Dongelmans, D A, Franke, H S, Galek-Aldridge, M S, de Graaff, M J, Hagens, L A, Haringman, J J, van der Heide, S T, van der Heiden, P L J, Heijnen, N F L, Hiel, S J P, Hoeijmakers, L L, Hol, L, Hollmann, M W, Hoogendoorn, M E, van der Horst, R, Ie, E L K, Ivanov, D P, Juffermans, N, Kho, E, de Klerk, E S, Koopman-van Gemert, A W M M, Koopmans, M, Kucukcelebi, S, Kuiper, M A, de Lange, D W, van Mourik, N, Nijbroek, S G L H, Onrust, M, Oostdijk, E A N, Pennartz, C J, Pisani, L, Purmer, I M, Rettig, T C D, Roozeman, J P, Schuijt, M T U, Schultz, M J, Serpa Neto, A, Sleeswijk, M E, Smit, M R, Spronk, P E, Stilma, W, Strang, A C, Tsonas, A M, Tuinman, P R, Valk, C M A, Veen-Schra, F L, Veldhuis, L I, van Velzen, P, van der Ven, W H, Vlaar, A P J, van Vliet, P, van der Voort, P H J, van Welie, L, Wesselink, H J F T, van der Wier-Lubbers, H H, van Wijk, B, Winters, T, Wong, W Y & van Zanten, A R H 2021, ' Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID) : a national, multicentre, observational cohort study ', The Lancet Respiratory Medicine, vol. 9, no. 2, pp. 139-148 . https://doi.org/10.1016/S2213-2600(20)30459-8
The Lancet Respiratory medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory Medicine
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier Ltd.
The Lancet Respiratory Medicine, 9(2), 139-148. Elsevier Limited
The Lancet Respiratory Medicine
The Lancet. Respiratory Medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier
Botta, M, Tsonas, A M, Pillay, J, Boers, L S, Algera, A G, Bos, L D J, Dongelmans, D A, Hollmann, M W, Horn, J, Vlaar, A P J, Schultz, M J, Neto, A S, Paulus, F, van Akkeren, J P, Algoe, C K, van Amstel, R B, Baur, O L, van de Berg, P, van den Berg, A E, Bergmans, D C J J, van den Bersselaar, D I, Bertens, F A, Bindels, A J G H, de Boer, M M, den Boer, S, Boers, L S, Bogerd, M, Bos, L D J, Breel, J S, de Bruin, H, de Bruin, S, Bruna, C L, Buiteman-Kruizinga, L A, Cremer, O L, Determann, R M, Dieperink, W, Dongelmans, D A, Franke, H S, Galek-Aldridge, M S, de Graaff, M J, Hagens, L A, Haringman, J J, van der Heide, S T, van der Heiden, P L J, Heijnen, N F L, Hiel, S J P, Hoeijmakers, L L, Hol, L, Hollmann, M W, Hoogendoorn, M E, van der Horst, R, Ie, E L K, Ivanov, D P, Juffermans, N, Kho, E, de Klerk, E S, Koopman-van Gemert, A W M M, Koopmans, M, Kucukcelebi, S, Kuiper, M A, de Lange, D W, van Mourik, N, Nijbroek, S G L H, Onrust, M, Oostdijk, E A N, Pennartz, C J, Pisani, L, Purmer, I M, Rettig, T C D, Roozeman, J P, Schuijt, M T U, Schultz, M J, Serpa Neto, A, Sleeswijk, M E, Smit, M R, Spronk, P E, Stilma, W, Strang, A C, Tsonas, A M, Tuinman, P R, Valk, C M A, Veen-Schra, F L, Veldhuis, L I, van Velzen, P, van der Ven, W H, Vlaar, A P J, van Vliet, P, van der Voort, P H J, van Welie, L, Wesselink, H J F T, van der Wier-Lubbers, H H, van Wijk, B, Winters, T, Wong, W Y & van Zanten, A R H 2021, ' Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID) : a national, multicentre, observational cohort study ', The Lancet Respiratory Medicine, vol. 9, no. 2, pp. 139-148 . https://doi.org/10.1016/S2213-2600(20)30459-8
The Lancet Respiratory medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory Medicine
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier Ltd.
The Lancet Respiratory Medicine, 9(2), 139-148. Elsevier Limited
The Lancet Respiratory Medicine
Background: Little is known about the practice of ventilation management in patients with COVID-19. We aimed to describe the practice of ventilation management and to establish outcomes in invasively ventilated patients with COVID-19 in a single coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb49ed3f5dbc71da01885fe1771742e
https://pure.amc.nl/en/publications/ventilation-management-and-clinical-outcomes-in-invasively-ventilated-patients-with-covid19-proventcovid-a-national-multicentre-observational-cohort-study(46a37e67-7c55-40c3-a572-4d55fd0af420).html
https://pure.amc.nl/en/publications/ventilation-management-and-clinical-outcomes-in-invasively-ventilated-patients-with-covid19-proventcovid-a-national-multicentre-observational-cohort-study(46a37e67-7c55-40c3-a572-4d55fd0af420).html
Autor:
Fleur M, van der Valk, Simone L, Verweij, Koos A H, Zwinderman, Aart C, Strang, Yannick, Kaiser, Henk A, Marquering, Aart J, Nederveen, Erik S G, Stroes, Hein J, Verberne, James H F, Rudd
Publikováno v:
Jacc. Cardiovascular Imaging
Objectives This study assessed 5 frequently applied arterial 18fluorodeoxyglucose (18F-FDG) uptake metrics in healthy control subjects, those with risk factors and patients with cardiovascular disease (CVD), to derive uptake thresholds in each subjec
Autor:
Matthias Laudes, Aart C. Strang, Paul P. Tak, R. Bisoendial, Erik S.G. Stroes, Marc R. Kok, Uwe J. F. Tietge, Ruud S. Kootte, Dominik M. Schulte, Johannes H.M. Levels, Danielle M. Gerlag, Sander W. Tas, N Müller, Geesje M. Dallinga-Thie, Koen Vos
Publikováno v:
Atherosclerosis, 229(1), 174-181. Elsevier Ireland Ltd
ATHEROSCLEROSIS, 229(1), 174-181. ELSEVIER IRELAND LTD
ATHEROSCLEROSIS, 229(1), 174-181. ELSEVIER IRELAND LTD
Objectives: Blocking the interleukin-6 pathway by tocilizumab (TCZ) has been associated with changes in the lipoprotein profile, which could adversely impact cardiovascular (CV) risk in patients with rheumatoid arthritis (RA). In the present study, w
Autor:
Hein J. Verberne, Sophie J. Bernelot Moens, Erik S.G. Stroes, Simone L. Verweij, Fleur M. van der Valk, Michael T. Nurmohamed, Aart C. Strang, Dominique Baeten, Aart J. Nederveen
Publikováno v:
van der Valk, F M, Moens, S J B, Verweij, S L, Strang, A C, Nederveen, A J, Verberne, H J, Nurmohamed, M T, Baeten, D L & Stroes, E S G 2016, ' Increased arterial wall inflammation in patients with ankylosing spondylitis is reduced by statin therapy ', Annals of the Rheumatic Diseases, vol. 75, no. 10, pp. 1848-1851 . https://doi.org/10.1136/annrheumdis-2016-209176
Annals of the Rheumatic Diseases, 75(10), 1848-1851. BMJ Publishing Group
Annals of the rheumatic diseases, 75(10), 1848-1851. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 75(10), 1848-1851. BMJ Publishing Group
Annals of the rheumatic diseases, 75(10), 1848-1851. BMJ Publishing Group
Annals of the Rheumatic Diseases
Background Ankylosing spondylitis (AS) is a chronic inflammatory disease with involvement of axial and sacroiliac joints. In addition, patients with AS have increased risk of cardiovascular disease (CVD), which might be attributed to enhanced inflamm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9faae3faa4d699d87b8382d5fbb7ae
https://research.vumc.nl/en/publications/762c12fb-b1ad-4983-812f-3979deff9732
https://research.vumc.nl/en/publications/762c12fb-b1ad-4983-812f-3979deff9732